Scholars Central

Conference proceedingPublished Aug 2020

Human Leukocyte Antigen G as a Novel Target for Switch-based Chimeric Antigen Receptor Natural Killer Cell Therapy of Solid Cancer

Authors: peter D Canoll

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Challenges present with chimeric antigen receptors (CARs) adoptive cell therapy against solid tumors have been lacking a ubiquitous tumor-associated antigen across different tumor types, tumor antigen expression heterogeneity, and the immunosuppressive nonphysical tumor microenvironment. Thus, we developed a switch anti human leukocyte antigen (HLA)-G CAR that binds to HLA-G1~G7

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in International Journal of Inflammation, Cancer and Integrative Therapy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalInternational Journal of Inflammation, Cancer and Integrative Therapy
  • SubjectImmunology & Microbiology
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “peter D Canoll”